Management of pediatric hemolytic uremic syndrome
Classical clinical triad of hemolytic uremic syndrome (HUS) is microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury associated with endothelial cell injury. Several situations, including infections, medications, malignancies, and transplantation can trigger endothelial damag...
Saved in:
| Main Authors: | Bora Gülhan, Fatih Özaltın, Kibriya Fidan, Zeynep Birsin Özçakar, Oğuz Söylemezoğlu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2024-02-01
|
| Series: | The Turkish Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://turkjpediatr.org/article/view/5100 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Household transmission and carriage of Shiga toxin-producing Escherichia coli (STEC) O145, Stx1c: a family report
by: Elif Okumuş, et al.
Published: (2025-07-01) -
Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome
by: Xinlei Sun, et al.
Published: (2025-01-01) -
Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden
by: Ying Hua, et al.
Published: (2020-01-01) -
A presentation of posterior reversible encephalopathy syndrome after heart transplantation: a case report and review of literature
by: Daniel Grandmougin, et al.
Published: (2025-08-01) -
INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome
by: Marta Rivas, et al.
Published: (2025-06-01)